HHCZX: Highland Healthcare Opportunities Fund - MutualFunds.com
Continue to site >
Trending ETFs

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$16.19

-

-

$0.00

2.40%

Vitals

YTD Return

-15.6%

1 yr return

0.4%

3 Yr Avg Return

7.4%

5 Yr Avg Return

7.6%

Net Assets

$21 M

Holdings in Top 10

71.0%

52 WEEK LOW AND HIGH

$16.33
$15.81
$20.57

Expenses

OPERATING FEES

Expense Ratio 2.40%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 168.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$2,500

IRA

$50


Fund Classification

Fund Type

Open End Mutual Fund

Investment Style

Long-Short Equity


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$16.19

-

-

$0.00

2.40%

HHCZX - Profile

Distributions

  • YTD Total Return -15.6%
  • 3 Yr Annualized Total Return 7.4%
  • 5 Yr Annualized Total Return 7.6%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -1.68%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Highland Healthcare Opportunities Fund
  • Fund Family Name
    Highland Funds
  • Inception Date
    May 05, 2008
  • Shares Outstanding
    393481
  • Share Class
    Inst
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    James Dondero

Fund Description

The fund seeks to achieve its investment objective by investing at least 80% of the value of its total assets (net assets plus any borrowings for investment purposes) under normal circumstances in securities of companies principally engaged in the design, development, production, sale, management or distribution of products, services or facilities used for or in connection with healthcare or medicine ("healthcare companies"). It is non-diversified.


HHCZX - Performance

Return Ranking - Trailing

Period HHCZX Return Category Return Low Category Return High Rank in Category (%)
YTD -15.6% -24.6% 35.6% 95.07%
1 Yr 0.4% -17.9% 67.9% 92.57%
3 Yr 7.4%* -10.3% 22.3% 39.78%
5 Yr 7.6%* -4.9% 20.5% 44.97%
10 Yr 5.1%* -5.8% 12.0% 64.41%

* Annualized

Return Ranking - Calendar

Period HHCZX Return Category Return Low Category Return High Rank in Category (%)
2020 22.2% -47.6% 88.4% 11.28%
2019 11.4% -20.3% 62.6% 36.56%
2018 12.7% -53.1% 12.7% 0.56%
2017 7.6% -67.1% 21.9% 43.56%
2016 -14.7% -17.3% 25.3% 96.38%

Total Return Ranking - Trailing

Period HHCZX Return Category Return Low Category Return High Rank in Category (%)
YTD -15.6% -24.6% 35.6% 95.07%
1 Yr 0.4% -17.9% 67.9% 91.58%
3 Yr 7.4%* -11.4% 22.3% 37.63%
5 Yr 7.6%* -5.4% 20.5% 43.20%
10 Yr 5.1%* -5.8% 12.0% 62.71%

* Annualized

Total Return Ranking - Calendar

Period HHCZX Return Category Return Low Category Return High Rank in Category (%)
2020 22.2% -47.6% 88.4% 11.28%
2019 11.4% -20.3% 62.6% 36.56%
2018 12.7% -53.1% 12.7% 0.56%
2017 8.8% -12.7% 24.8% 55.83%
2016 -14.7% -15.5% 25.3% 97.83%

NAV & Total Return History


HHCZX - Holdings

Concentration Analysis

HHCZX Category Low Category High HHCZX % Rank
Net Assets 21 M 0 5.19 B 79.23%
Number of Holdings 31 3 3156 74.51%
Net Assets in Top 10 19.2 M -87.9 M 765 M 53.92%
Weighting of Top 10 70.95% 4.8% 100.0% 14.62%

Top 10 Holdings

  1. Dreyfus Treasury Obligations Csh Mgt Ins 20.81%
  2. Bio-Rad Laboratories Inc 9.90%
  3. uniQure NV 7.97%
  4. NextCure Inc 6.97%
  5. AbbVie Inc 6.25%
  6. Atai Life Science. 6.15%
  7. Humana Inc 5.10%
  8. Organon & Co Ordinary Shares 5.03%
  9. Berkeley Lights Inc Ordinary Shares 4.97%
  10. Singular Genomics Systems Inc 4.81%

Asset Allocation

Weighting Return Low Return High HHCZX % Rank
Stocks
88.14% -17.84% 113.92% 20.87%
Cash
11.86% -140.68% 117.83% 70.59%
Preferred Stocks
0.00% -0.01% 8.88% 51.47%
Other
0.00% -16.93% 36.41% 61.76%
Convertible Bonds
0.00% 0.00% 3.02% 53.92%
Bonds
0.00% -0.70% 152.17% 60.68%

Stock Sector Breakdown

Weighting Return Low Return High HHCZX % Rank
Healthcare
100.00% 0.00% 100.00% 1.05%
Utilities
0.00% 0.00% 23.92% 86.91%
Technology
0.00% 0.00% 48.18% 98.43%
Real Estate
0.00% 0.00% 17.36% 90.05%
Industrials
0.00% 0.00% 35.91% 97.38%
Financial Services
0.00% 0.00% 74.33% 97.91%
Energy
0.00% 0.00% 12.98% 94.24%
Communication Services
0.00% 0.00% 29.68% 98.95%
Consumer Defense
0.00% 0.00% 28.39% 95.29%
Consumer Cyclical
0.00% 0.00% 83.72% 99.48%
Basic Materials
0.00% 0.00% 21.97% 93.19%

Stock Geographic Breakdown

Weighting Return Low Return High HHCZX % Rank
US
70.45% -43.02% 113.00% 32.84%
Non US
17.69% -31.09% 98.73% 16.67%

HHCZX - Expenses

Operational Fees

HHCZX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 2.40% 0.40% 12.79% 26.09%
Management Fee 1.00% 0.00% 2.50% 34.78%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee 0.20% 0.03% 1.54% 66.67%

Sales Fees

HHCZX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 4.00% N/A

Trading Fees

HHCZX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.50% 2.00% 33.93%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

HHCZX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 168.00% 0.00% 498.00% 53.66%

HHCZX - Distributions

Dividend Yield Analysis

HHCZX Category Low Category High HHCZX % Rank
Dividend Yield 0.00% 0.00% 1.80% 50.24%

Dividend Distribution Analysis

HHCZX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Monthly Annually

Net Income Ratio Analysis

HHCZX Category Low Category High HHCZX % Rank
Net Income Ratio -1.68% -3.33% 2.81% 88.44%

Capital Gain Distribution Analysis

HHCZX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Dividend Payout History

View More +

HHCZX - Fund Manager Analysis

Managers

James Dondero


Start Date

Tenure

Tenure Rank

Mar 29, 2018

3.43

3.4%

Mr. Dondero is also the co-founder and President of Highland, founder and President of NexPoint Advisors, L.P., Chairman of the board of directors, Chief Executive Officer and member of the investment committee of NXRT, President of NexPoint Capital, Inc., President of NMCT, director for American Banknote Corporation, director for Metro-Goldwyn-Mayer, director for Jernigan Capital, Inc., Chairman of the board of directors for Cornerstone Healthcare, Chairman of the board of directors for CCS Medical, and Chairman of NexBank, an affiliated bank that is majority owned by Mr. Dondero. Mr. Dondero has over 30 years of experience investing in credit and equity markets and has helped pioneer credit asset classes. Prior to founding Highland Capital Management in 1993, Mr. Dondero served as Chief Investment Officer of Protective Life’s GIC subsidiary and helped grow the business between 1989 and 1993. His portfolio management experience includes mortgage-backed securities, investment grade corporates, leveraged bank loans, high-yield bonds, emerging market debt, real estate, derivatives, preferred stocks and common stocks. From 1985 to 1989, he managed in fixed income funds for American Express. Mr. Dondero received a BS in Commerce (Accounting and Finance) from the University of Virginia, and is a Certified Managerial Accountant and a Chartered Financial Analyst.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.04 22.8 5.82 7.18